SEC. 2. NATIONAL CONGENITAL HEART DISEASE SURVEIL-
LANCE SYSTEM. 
Section 399V–2 of the Public Health Service Act (42 
U.S.C. 280g–13) is amended to read as follows: 
‘‘SEC. 399V–2. NATIONAL CONGENITAL HEART DISEASE RE-
SEARCH, SURVEILLANCE, AND AWARENESS. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention, shall— 
‘‘(1) enhance and expand research and surveil-
lance infrastructure to study and track the epidemi-
ology of congenital heart disease (in this section re-
ferred to as ‘CHD’); 
‘‘(2) plan and implement a public outreach and 
education campaign regarding CHD across the life-
span; and 
‘‘(3) award grants to eligible entities to under-
take the activities described in subsections (b) and 
(c). 
‘‘(b) NATIONAL CONGENITAL HEART DISEASE CO-
HORT STUDY.— 
‘‘(1) IN GENERAL.—The Director of the Cen-
ters for Disease Control and Prevention shall plan, 
develop, implement, and submit one or more reports 
to the Congress on a cohort study to improve under-
standing of the epidemiology of CHD across the life-
VerDate Sep 11 2014 
23:10 Nov 07, 2015
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3952.IH
H3952
tkelley on DSK3SPTVN1PROD with BILLS
span, from birth to adulthood, with particular inter-
est in the following: 
‘‘(A) Health care utilization and natural 
history of those affected by CHD. 
‘‘(B) Demographic factors associated with 
CHD, such as age, race, ethnicity, gender, and 
family history of individuals who are diagnosed 
with the disease. 
‘‘(C) Outcome measures, such that analysis 
of the outcome measures will allow derivation of 
evidence-based best practices and guidelines for 
CHD patients. 
‘‘(2) 
PERMISSIBLE
CONSIDERATIONS.—The 
study under this subsection may— 
‘‘(A) gather data on the health outcomes of 
a diverse population of those affected by CHD; 
‘‘(B) consider health disparities among 
those affected by CHD which may include the 
consideration of prenatal exposures; and 
‘‘(C) incorporate behavioral, emotional, 
and educational outcomes of those affected by 
CHD. 
‘‘(3) PUBLIC
ACCESS.—Subject to paragraph 
(4), the data generated from the study under this 
VerDate Sep 11 2014 
23:10 Nov 07, 2015
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3952.IH
H3952
tkelley on DSK3SPTVN1PROD with BILLS
subsection shall be made available to the public, in-
cluding CHD researchers. 
‘‘(4) PATIENT PRIVACY.—The Secretary shall 
ensure that the study under this subsection is car-
ried out in a manner that complies with the require-
ments applicable to a covered entity under the regu-
lations promulgated pursuant to section 264(c) of 
the Health Insurance Portability and Accountability 
Act of 1996. 
‘‘(c) CONGENITAL
HEART
DISEASE
AWARENESS 
CAMPAIGN.— 
‘‘(1) IN GENERAL.—The Director of the Cen-
ters for Disease Control and Prevention shall estab-
lish and implement an awareness, outreach, and 
education campaign regarding CHD across the life-
span. The information expressed through such cam-
paign shall— 
‘‘(A) emphasize that CHD is the most 
prevalent birth defect; 
‘‘(B) identify CHD as a condition that af-
fects those diagnosed throughout their lives; 
and 
‘‘(C) promote the need for pediatric, ado-
lescent, and adult individuals with CHD to seek 
and maintain lifelong, specialized care. 
VerDate Sep 11 2014 
23:10 Nov 07, 2015
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3952.IH
H3952
tkelley on DSK3SPTVN1PROD with BILLS
‘‘(2) PERMISSIBLE ACTIVITIES.—The campaign 
under this subsection may— 
‘‘(A) utilize collaborations or partnerships 
with other agencies, health care professionals, 
and patient advocacy organizations that spe-
cialize in the needs of individuals with CHD; 
and 
‘‘(B) include the use of print, film, and 
electronic materials distributed via television, 
radio, Internet, and other commercial mar-
keting venues. 
‘‘(d) ELIGIBILITY FOR GRANTS.—To be eligible to re-
ceive a grant under subsection (a)(3), an entity shall— 
‘‘(1) be a public or private nonprofit entity with 
specialized experience in CHD; and 
‘‘(2) submit to the Secretary an application at 
such time, in such manner, and containing such in-
formation as the Secretary may require. 
‘‘(e) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $4,000,000 for each of fiscal years 2016 through 
2020.’’. 
SEC. 3. CONGENITAL HEART DISEASE RESEARCH. 
Section 425 of the Public Health Service Act (42 
U.S.C. 285b–8) is amended to read as follows: 
VerDate Sep 11 2014 
23:10 Nov 07, 2015
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H3952.IH
H3952
tkelley on DSK3SPTVN1PROD with BILLS
‘‘SEC. 425. CONGENITAL HEART DISEASE. 
‘‘(a) IN GENERAL.—The Director of the Institute 
may expand, intensify, and coordinate research and re-
lated activities of the Institute with respect to congenital 
heart disease, which may include congenital heart disease 
research with respect to— 
‘‘(1) causation of congenital heart disease, in-
cluding genetic causes; 
‘‘(2) long-term outcomes in individuals with 
congenital heart disease, including infants, children, 
teenagers, adults, and elderly individuals; 
‘‘(3) diagnosis, treatment, and prevention; 
‘‘(4) studies using longitudinal data and retro-
spective analysis to identify effective treatments and 
outcomes for individuals with congenital heart dis-
ease; and 
‘‘(5) identifying barriers to lifelong care for in-
dividuals with congenital heart disease. 
‘‘(b) COORDINATION OF RESEARCH ACTIVITIES.— 
The Director of the Institute may coordinate research ef-
forts related to congenital heart disease among multiple 
research institutions and may develop research networks. 
‘‘(c) MINORITY
AND
MEDICALLY
UNDERSERVED 
COMMUNITIES.—In carrying out the activities described in 
this section, the Director of the Institute shall consider 
VerDate Sep 11 2014 
05:22 Nov 10, 2015
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3952.IH
H3952
tkelley on DSK3SPTVN1PROD with BILLS
the application of such research and other activities to mi-
nority and medically underserved communities. 
‘‘(d) REPORT FROM NIH.—Not later than 1 year 
after the date of enactment of the Congenital Heart Fu-
tures Reauthorization Act of 2015, the Director of NIH, 
acting through the Director of the Institute, shall provide 
a report to Congress— 
‘‘(1) outlining the ongoing research efforts of 
the National Institutes of Health regarding con-
genital heart disease; and 
‘‘(2) identifying— 
‘‘(A) future plans for research regarding 
congenital heart disease; and 
‘‘(B) the areas of greatest need for such 
research.’’. 
Æ 
VerDate Sep 11 2014 
23:10 Nov 07, 2015
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H3952.IH
H3952
tkelley on DSK3SPTVN1PROD with BILLS